CELC – celcuity inc. (US:NASDAQ)
Stock Stats
News
12/17
10:32 am
celc
Low
How Investors Are Reacting To Celcuity (CELC) Gedatolisib's Phase 3 Breast Cancer Data And Safety Profile [Yahoo! Finance]
12/16
09:27 pm
celc
Low
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation [Yahoo! Finance]
12/13
07:49 am
celc
Medium
Celcuity (NASDAQ:CELC) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
12/12
07:12 am
celc
Medium
Celcuity (NASDAQ:CELC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
12/11
03:16 pm
celc
Low
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
11/12/2025
04:01 pm
CELC
2.8%
BEAT
8/14/2025
04:01 pm
CELC
-0.2%
MISS
5/14/2025
04:01 pm
CELC
-3.1%
BEAT
3/31/2025
04:01 pm
CELC
-8.1%
MISS
12/13
07:49 am
Upgrades
Strong-Buy
Wells Fargo & Company
Medium
-4.1%
12/12
11:34 am
Initiates
Overweight
Wells Fargo
Low
-2.4%
12/12
11:34 am
Initiates
Overweight
Wells Fargo
Low
-2.4%
12/12
07:12 am
Initiates
Overweight
Wells Fargo & Company
Medium
4.2%
12/12
06:38 am
Initiates
OVERWEIGHT
WELLS FARGO
Medium
4.2%
12/9
04:23 pm
celc
Low
Form 4 Celcuity Inc. For: Dec 05 Filed by: Buller Richard E
12/8
04:31 pm
celc
Medium
Form 4 Celcuity Inc. For: Dec 04 Filed by: Furcht Leo
12/5
05:31 pm
celc
Low
Form 144 Celcuity Inc. Filed by: Buller Richard E
12/3
04:10 pm
celc
Medium
Form 4 Celcuity Inc. For: Dec 01 Filed by: Buller Richard E
12/1
05:46 pm
celc
Low
Form 144 Celcuity Inc. Filed by: Buller Richard E
Show more
Top News Gainers
3/18 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 7.9%
4/23 Celcuity Inc. Schedules Release of First Quarter 2020 Financial Results and Conference Call 7.6%
5/8 Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 3.2%
7/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 2.8%
5/20 Celcuity Announces Appointment of Leo Furcht to Board of Directors 2.1%
11/7 Q3/2019 9/30/2019 EPS -0.160 ZacksConsensus -0.180 ActVsEst 0.020 - Beat 1.9%
8/8 Celcuity Reports Second Quarter 2019 Financial Results 1.6%
1/13 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.5%
2/24 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.5%
5/20 Form 4 Celcuity Inc. For: May 16 Filed by: NIGON RICHARD 1.4%
Top News Decliners
2/14 Form SC 13G/A Celcuity Inc. Filed by: Sullivan Brian F. -5.1%
8/1 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. -4.3%
3/13 Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock, down previously from $36.00. -3.6%
10/9 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -3.3%
8/10 Celcuity's (CELC) CEO Brian Sullivan on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -1.9%
11/20 Celcuity Inc (NASDAQ: CELC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -1.1%
7/25 Celcuity Inc. Schedules Release of Second Quarter 2019 Financial Results and Conference Call -1.1%
12/11 Celcuity Presents Results at the 2019 San Antonio Breast Cancer Symposium Evaluating a Sub-Group of PIK3CA WT Breast Cancer Patients Who Have Hyperactive Signaling Tumors Responsive to PI3K Inhibitors -0.9%
11/11 Celcuity Inc (NASDAQ: CELC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/27 Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call -0.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3